Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luke Jonathan Alvey"'
Autor:
Alain Monjardet, Thierry Christophe, Nicolas Triballeau, Helene Jary, Luke Jonathan Alvey, Romain Luc Marie Gosmini, Frédéric André De Ceuninck, Pierre Deprez, Robert Touitou, Roland Blanque, D. Amantini, Nele Vandervoort, Ellen van der Aar, Philip Leonard, F. Brebion, Patrick Mollat, Natacha Bienvenu, C. Cottereaux, I. Botez, Varin Marie Laurence Claire, Christophe Peixoto
Publikováno v:
Journal of Medicinal Chemistry. 64:2937-2952
There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore, ADAMTS-5 is a promising target for the identificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63e1d09bcd2c3ffc719892459e89ab3
https://doi.org/10.1021/acs.jmedchem.0c02008
https://doi.org/10.1021/acs.jmedchem.0c02008
Autor:
Graeme Milligan, Luke Jonathan Alvey, Annick Hagers, Thierry Christophe, Emanuelle Wakselman, Luc Nelles, Line Oste, Steve De Vos, Ann Vandevelde, Katja Conrath, Laurent Saniere, Stephen Robert Fletcher, Laura Jenkins, Sandrine Le Tallec, D. Merciris, Pierre Deprez, Roland Blanque, C. Cottereaux, Romain Luc Marie Gosmini, Ellen van der Aar, Cécile da Costa, Sonia Dupont, Thi Thu Trang Mai, Vanessa Quenehen, Labeguere Frederic Gilbert, Philippe Clément-Lacroix, Florilène Soulas, Reginald Brys, Gregory John Robert Newsome, Nele Vandervoort, Amynata Tirera
Publikováno v:
Journal of Medicinal Chemistry. 63:13526-13545
GPR84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory and fibrotic diseases. As the only reported antagonist of GPR84 (PBI-4050) that displays relatively low potency and selectivity, a clear need exis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8f803bd9662806c89d70fe1a829f85
https://doi.org/10.1021/acs.jmedchem.0c00272
https://doi.org/10.1021/acs.jmedchem.0c00272
Autor:
Catherine Robin-Jagerschmidt, Helene Jary, Ellen van der Aar, Nicolas Triballeau, Luke Jonathan Alvey, Francois Nique, Denis Guédin, Kris Van Beeck, Dominque Minet, Florence Namour, Jean H.M. Feyen, Pierre Deprez, Hugo Klaassen, Jean-Michel Lefrancois, Roland Blanque, Christophe Peixoto, Murielle Manioc, Séverine Hebbe, Stephen Robert Fletcher, Christopher Gaëtan Housseman
Publikováno v:
Journal of Medicinal Chemistry. 55:8236-8247
Structural modification performed on a 4-methyl-4-(4-hydroxyphenyl)hydantoin series is described which resulted in the development of a new series of 4-(hydroxymethyl)diarylhydantoin analogues as potent, partial agonists of the human androgen recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841982488e4fec11bfd3145a00ecb1c9
https://doi.org/10.1021/jm300281x
https://doi.org/10.1021/jm300281x